BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 7776938)

  • 1. [Torsade de pointes and QT syndrome].
    Haverkamp W; Hördt M; Borggrefe M; Breithardt G
    Med Klin (Munich); 1995 Apr; 90(4):240-5. PubMed ID: 7776938
    [No Abstract]   [Full Text] [Related]  

  • 2. Early afterdepolarizations, U waves, and torsades de pointes.
    Wu J; Wu J; Zipes DP
    Circulation; 2002 Feb; 105(6):675-6. PubMed ID: 11839619
    [No Abstract]   [Full Text] [Related]  

  • 3. [Torsade de pointes].
    Haverkamp W; Hördt M; Chen X; Hindricks G; Willems S; Kottkamp H; Rotman B; Brunn J; Borggrefe M; Breithardt G
    Z Kardiol; 1993 Dec; 82(12):763-74. PubMed ID: 8147050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amiodarone-associated macroscopic T-wave alternans and torsade de pointes unmasking the inherited long QT syndrome.
    Wegener FT; Ehrlich JR; Hohnloser SH
    Europace; 2008 Jan; 10(1):112-3. PubMed ID: 18006559
    [No Abstract]   [Full Text] [Related]  

  • 5. Long QT Syndrome and Torsade de Pointes Ultimately Treated With Quinidine: Introducing the Concept of Pseudo-Torsade de Pointes.
    Viskin S; Marai I; Rosso R
    Circulation; 2021 Jul; 144(1):85-89. PubMed ID: 34228481
    [No Abstract]   [Full Text] [Related]  

  • 6. QT interval prolongation and torsade de pointes.
    Patanè S; Marte F; Di Bella G
    Int J Cardiol; 2009 Jan; 131(2):e51-3. PubMed ID: 17689729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hands-on help Torsades de pointes.
    Dulak SB
    RN; 2004 Oct; 67(10):24ac1-4. PubMed ID: 15552376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent Torsade de Pointes during mild hypothermia therapy for a survivor of sudden cardiac arrest due to drug-induced long-QT syndrome.
    Matsuhashi T; Sato T; Aizawa Y; Takatsuki S
    J Cardiovasc Electrophysiol; 2010 Apr; 21(4):462-3. PubMed ID: 19845813
    [No Abstract]   [Full Text] [Related]  

  • 9. Torsade de pointes: the clinical considerations.
    Gowda RM; Khan IA; Wilbur SL; Vasavada BC; Sacchi TJ
    Int J Cardiol; 2004 Jul; 96(1):1-6. PubMed ID: 15203254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Takotsubo cardiomyopathy as a potential cause of long QT syndrome and torsades de pointes.
    Ghosh S; Apte P; Maroz N; Broor A; Zeineh N; Khan IA
    Int J Cardiol; 2009 Aug; 136(2):225-7. PubMed ID: 18617280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Earthquake-Induced Torsade de Pointes in Long-QT Syndrome.
    Nakagawa S; Aiba T; Nakajima K; Kataoka N; Kamakura T; Wada M; Ishibashi K; Yamagata K; Inoue Y; Miyamoto K; Nagase S; Noda T; Miyamoto Y; Yasuda S; Shimizu W; Kusano K
    Circ J; 2019 Aug; 83(9):1968. PubMed ID: 30842358
    [No Abstract]   [Full Text] [Related]  

  • 12. Revised definition of M cell and torsade de pointes in long QT syndrome.
    Takahashi N
    J Cardiovasc Electrophysiol; 2005 Sep; 16(9):988-90. PubMed ID: 16174021
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diagnostic and therapeutic problems in idiopathic prolonged QT syndrome. A case report].
    Haverkamp W; Block M; Wichter T; Hindricks G; Brunn J; Borggrefe M; Breithardt G
    Z Kardiol; 1993 Apr; 82(4):237-42. PubMed ID: 8506718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QT interval lengthening after fasting complicated by a sudden attack of torsades de pointes.
    Petrov DB
    Tex Heart Inst J; 2003; 30(1):86-7. PubMed ID: 12638683
    [No Abstract]   [Full Text] [Related]  

  • 15. QT interval prolongation, torsade de pointes and renal disease.
    Patanè S; Marte F; Di Bella G; Currò A; Coglitore S
    Int J Cardiol; 2008 Nov; 130(2):e71-3. PubMed ID: 18255176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of pharmacological treatment and genetic characterization in early diagnosed patients affected by long QT syndrome with impaired AV conduction.
    Sarubbi B; Frisso G; Romeo E; Evangelista E; Cordella A; D'Alto M; Santarpia G; Russo MG; Salvatore F; Calabrò R
    Int J Cardiol; 2011 May; 149(1):109-13. PubMed ID: 21481956
    [No Abstract]   [Full Text] [Related]  

  • 17. [Acquired long QT syndrome with torsade de pointes in a patient with primary hypothyroidism].
    Kukla P; Szczuka K; Słowiak-Lewińska T; Bromblik A; Hajduk B; Kluczewski M; Lenard B; Przewor M
    Kardiol Pol; 2003 Mar; 58(3):224-6. PubMed ID: 14513098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Takotsubo cardiomyopathy associated with torsades de pointes and long QT interval: a case report].
    Okada T; Miyata S; Hashimoto K; Maie K; Mochizuki S
    J Cardiol; 2007 Jul; 50(1):83-8. PubMed ID: 17685032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Citalopram induced torsade de pointes, a rare life threatening side effect.
    Kanjanauthai S; Kanluen T; Chareonthaitawee P
    Int J Cardiol; 2008 Dec; 131(1):e33-4. PubMed ID: 17919753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current principles of the treatment of prolonged QT interval syndrome].
    Popov SV; Gimrikh EO; Pekarskiĭ VV
    Klin Med (Mosk); 1990 Nov; 68(11):8-12. PubMed ID: 1980933
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.